Bio-path Holdings Stock Forecast

Buy candidate since Jul 02, 2026

The Bio-Path Holdings stock price gained 34.29% on the last trading day (Thursday, 2nd Jul 2026), rising from $0.0350 to $0.0470. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 11.90% from a day low at $0.0420 to a day high of $0.0470. The price has risen in 6 of the last 10 days and is up by 30.56% over the past 2 weeks. Volume fell on the last day by -49 thousand shares and in total, 5 shares were bought and sold for approximately $0.235 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Given the current short-term trend, the stock is expected to fall -40.36% during the next 3 months and, with a 90% probability hold a price between $0.0054 and $0.0280 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BPTH Signals & Forecast

The Bio-Path Holdings stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0370 and $0.0339. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 90.28%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Bio-Path Holdings stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0410 and $0.0370. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Bio-Path Holdings finds support just below today's level at $0.0410. If this is broken, then the next support from accumulated volume will be at $0.0370 and $0.0360.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0050 between high and low, or 11.90%. For the last week the stock has had daily average volatility of 17.86%.

Our recommended stop-loss: $0.0454 (-3.44%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 30 days ago.)

Trading Expectations (BPTH) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Bio-Path Holdings to open at $0.0453, and during the day (based on 14 day Average True Range), to move between $0.0420 and $0.0520, which gives a possible trading interval of +/-$0.0099 (+/-23.57%) up or down from last closing price. If Bio-Path Holdings takes out the full calculated possible swing range there will be an estimated 23.57% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0501 (6.60%) than the support at $0.0410 (12.77%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Bio-Path Holdings stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 4.375 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $0.0453 ( 3.55%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk